Let's Move Forward Together
Let’s get ready to reconnect in Montpellier, France! We’re on a mission to change the way the world sees the genome with genome mapping systems, nucleic acid purification solutions, analysis soſtware, and clinical testing services. Come explore the genomic variation continuum, from SNVs to whole chromosomes, through our solutions. Together, we can reveal more variation that matters in cancer research and human genetic diseases.
Learn
This year’s ECA conference offers multiple opportunities to hear how optical genome mapping (OGM) from Bionano is uncovering genomic variations that other methods can’t, while VIA analysis software is opening a new era of fully contextualized genomic discovery. Come and learn how we’re impacting human genetic research.
Sponsored Session
Revolutionizing Cytogenomics with Optical Genome Mapping sample-to-answer workflow: Now powered by VIA software
-
Monday, 3 July 2023
-
12:15 - 1:00 PM
-
Pasteur Room
Dana Jaber, PhD | Bionano (USA)
“Introduction to Bionano sample-to-answer workflow”
Martine Doco-Fenzy, MD, PhD | CHU de Nantes (France)
“OGM contribution to the Etiological Diagnosis of Developmental disorders, experience of CHU Nantes Genetic Department”
- Discover results obtained with OGM in cases presenting malformation syndromes with or without intellectual disability (MSID), following cytogenetic and sequencing techniques that previously failed to identify causative variants.
Victoria Marcu, PhD | Sheba Medical Center (Israel)
“OGM for Hematological Malignancies – Sheba Experience”
- Learn how OGM produced additional relevant findings in heme samples compared to classical cytogenetic methods.
PLENARY SESSIONS – SELECTED ABSTRACTS
SUNDAY, 2 JULY | PASTEUR ROOM
Plenary Session 2 – Cancer Cytogenomics
11:45 AM – 12:00 PM | Christina Srouji (Rambam health Hospital, Israel) – “Optical Genome Mapping for Multiple Myeloma: Evaluation of The Technology in a Clinical Laboratory”
Concurrent Session 3 – Recent Advances in Cytogenomics
14:30 – 15:00 PM | Alex Hoischen (Radboud UMC, Netherlands) – “Optical Mapping to Karyotype”
15:30 – 15:45 PM | Gil Nifker (Gamidor, Israel) – “Dam Assisted Fluorescent Tagging of Chromatin Accessibility (DAFCA) for Optical Genome Mapping in Nano-Channel Arrays”
Dana Jaber, PhD
Bionano (USA)
Martine Doco-Fenzy, MD, PhD
Clinician & Biologist in Cytogenetics, CHU de Nantes
Victoria Marcu, PhD
Cytogenetic Unit Head, Laboratory of Hematology - Chaim Sheba Medical Center
Don’t miss the latest research at the Poster Sessions!
Poster SessionsConnect
If you’re curious about OGM and wondering how it connects to your work, stop by and talk to one of our dedicated team members. We can’t wait to share our enthusiasm for technology that is moving clinical research forward in remarkable ways.
Booth #12
Look for our team in the Exhibit Hall, ready to share the latest research and new product information with you. Stop by to see our Saphyr and Ionic instruments, get a soſtware demo, and learn more about our products and services. We can't wait to hear more about your research challenges and how we can help you find more genomic variation that matters.
OGM is Now Powered By VIA
A faster and more complete genomic data analysis platform for clinical research.
Existing data analysis solutions for genomics are laborious, time-consuming and incomplete. You have to manage various systems, navigate complex workflows and spend inordinate amounts of time hunting for annotations and creating data visualizations. Good news: those days are over.
Visit our Booth # at ECA to learn more about the new VIA software analysis tool.
Learn More About VIA
Poster Sessions
See all the latest research on our solutions at the poster session. Oral presentations will be held in their designated locations.
Selected Abstracts for Oral Presentation | Saturday, 1 July 2023
(please see table below for more poster and speaker information)
15:15 PM | P1003 | Ros Hastings | Room Barthez
15:14 PM | P1052 | Victoria Marcu | Room Sully 2
15:30 PM | P1032 | Vasheghani Farahani Faezeh | Room Rondollet
16:56 PM | P1101 | Anna Schachner | Room Barthez
16:40 PM | P1095 | Christina Pérez | Room Sully 2
| POSTER | TITLE | LEAD AUTHOR |
|---|---|---|
| P1003 | Genome Mapping (optical and electronic) nomenclature and ISCN 2024. |
Ros Hastings
(GenQA, UK) |
| P1052 | Validation of the OGM for cytogenomic testing in hemato-oncology – Sheba Medical Center experience |
Victoria Marcu
(Sheba Hospital, Israel) |
| P1032 | Optical Genome Mapping Comparing OGM with other Cytogenomics technologies. Experience on 60 individuals with developmental or fertility disorders. |
Vasheghani Farahani Faezeh and Doco-Fenzy Martine
(CHU de Nantes, France) |
| P1101 | Monitoring of long term cultured induced pluripotent stem cells by Optical Genome Mapping (OGM) confirms sustained fine structural genomic stability across more than 60 in vitro passages. |
Anna Schachner
(Institut Medizinische Genetik, Austria) |
| P1095 | Optical Genome Mapping (OGM) Validation and characterization of marker chromosomes. |
Christina Pérez
(Synlab, Spain) |
| P1022 | Optical Genome Mapping in Routine Cytogenetic Diagnosis of Acute Leukemia. |
Gwendoline Soler
(CHU Estaing – Clermont-Ferrand, France) |
| P1024 | Optical genome mapping in Leukemia demonstrates full concordance and new cytogenetic findings in an Israeli cohort. |
Nivin Moustafa-Hawash
(Rambam health Hospital, Israel) |
| P1060 | Optical genome mapping of bone-marrow in Hematological malignancies. |
Hila Nachmias
(ICHILOV, Israel) |
| P1075 | Optical Genome Mapping use in the multiple myeloma diagnosis. |
Catherine Menten
(CHU de Liège, Belgium) |
| P1089 | Optical mapping characterization of a very complex chromosomal insertion. |
Alberto Plaja
(Hospital Vall D'hebron Barcelona, Spain) |
| P1096 | Detection of 12;13 reciprocal translocation with copy number losses detected by karyotype and array and characterized by Optical Genome Mapping. |
Elisabet Lloveras
(Synlab, Spain) |
